Free Trial
OTCMKTS:JAPAY

Japan Tob Q2 2024 Earnings Report

Japan Tob logo
$19.04 +0.16 (+0.85%)
As of 01:16 PM Eastern

Japan Tob EPS Results

Actual EPS
$0.27
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Japan Tob Revenue Results

Actual Revenue
$5.32 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Japan Tob Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Japan Tob's next earnings date is estimated for Thursday, July 30, 2026, based on past reporting schedules.

Conference Call Resources

Japan Tob Earnings Headlines

Japan Tobacco: Steady As She Goes
Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all.tc pixel
Japan Tobacco: Poised To Outperform Japanese Equities
See More Japan Tob Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Japan Tob? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Japan Tob and other key companies, straight to your email.

About Japan Tob

Japan Tob (OTCMKTS:JAPAY)acco Inc. (OTC: JAPAY) is a Tokyo-based multinational company primarily engaged in the manufacture and sale of tobacco products. The company’s core activities include the development, production and distribution of cigarettes and other nicotine-delivery products for domestic and international markets. Japan Tobacco also pursues business activities beyond tobacco, including pharmaceutical and processed‑food operations through subsidiary units and strategic investments.

In its tobacco operations the company serves both the Japanese market and a broad international footprint through its global operating arm, Japan Tobacco International (JTI). Product offerings span conventional cigarette brands and a growing portfolio of reduced‑risk and alternative nicotine products intended to address changing consumer preferences and regulatory environments. The company’s commercial network includes manufacturing, marketing and distribution capabilities that support sales across Asia, Europe, the Americas and other regions.

Japan Tobacco was formed following the privatization of a state monopoly in the mid-1980s and has since expanded its global presence through organic growth and international acquisitions, building a diverse brand portfolio that includes well-known regional and international cigarette brands. The company has invested in product research and development to adapt to shifting demand and regulatory dynamics in the tobacco sector while managing non-tobacco businesses that provide additional revenue streams.

For investors and analysts, Japan Tobacco is typically evaluated on the strength of its brand portfolio, geographic diversification, regulatory exposure and progress in reduced‑risk product development. Detailed, up‑to‑date information on corporate leadership, governance and financial performance should be obtained from the company’s official filings and investor relations materials.

View Japan Tob Profile